Effect of Unani Medicine Lauq-e-Khayarshambar in Nazla (Common Cold)

Phase 2

• Conditions: Health Condition 1: J00-J99- Diseases of the respiratory systemHealth Condition 2: J459- Other and unspecified asthma

• Registration Number: CTRI/2018/08/015445
• Lead Sponsor: Central Council For Research In Unani Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1. Patients of either sex in the age group of 18-65

2. Patients of Nazla (Common Cold) presenting with recent onset of any of the following symptoms:

(i) Khushūna al-Halaq (Sore Throat)

(ii) Buhha al-Sawt Hoarseness / Change of Voice

(iii)â??UtÄ?s â??Sneezing/ Nasal irritation

(iv)Rhinorrhoea/Runny nose

(v)SudÄ?â?? Headache

(vi)Suâ??Ä?l Cough

(vii)Iâ??yÄ? Malaise

(viii)Low grade fever (100 - 101°F)

Exclusion Criteria

Any one of the following:

1. Patients of acute or chronic lower respiratory tract infection like pneumonia, Bronchitis, Asthma and Bronchiectasis.

2. High Grade Fever > 101oF

3. History of hepatic, renal disorders, diabetes mellitus, hypertension, anaemia, COPD or any other ailment requiring long term therapy

4. Known cases of any other acute illness

5. Pregnant and lactating women

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improvement in sign and symptoms of Nazla (Common Cold)Timepoint: Seven Days

Secondary Outcome Measures

Name	Time	Method
Hematological and biochemical assessment for safetyTimepoint: Seven Days